A multi-center, double-blind, randomized, placebo-controlled, two-arm, parallel-group, sleep lab trial to investigate the efficacy and safety of transdermal rotigotine in subjects with idiopathic restless legs syndrome.

Trial Profile

A multi-center, double-blind, randomized, placebo-controlled, two-arm, parallel-group, sleep lab trial to investigate the efficacy and safety of transdermal rotigotine in subjects with idiopathic restless legs syndrome.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Oct 2014

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Restless legs syndrome
  • Focus Registrational; Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 15 Sep 2009 Company UCB added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
    • 26 Aug 2008 Results have been published in the proceedings of the 12th Congress of the European Federation of Neurological Societies.
    • 19 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top